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The 5-carboxymethylaminomethyl modification of
uridine (cmnm5U) at the anticodon first position
occurs in tRNAs that read split codon boxes ending
with purine. This modification is crucial for correct
translation, by restrictingcodon-anticodonwobbling.
Two conserved enzymes, GidA and MnmE, partici-
pate in the cmnm5U modification process. Here we
determined the crystal structure of Aquifex aeolicus
GidA at 2.3 A˚ resolution. The structure revealed the
tight interaction of GidA with FAD. Structure-based
mutation analyses allowed us to identify two
conserved Cys residues in the vicinity of the FAD-
binding site that are essential for the cmnm5Umodifi-
cation in vivo. Together with mutational analysis of
MnmE, we propose a mechanism for the cmnm5U
modification process where GidA, but not MnmE,
attacks the C6 atom of uridine by a mechanism anal-
ogous to that of thymidylate synthase. We also
present a tRNA-docking model that provides struc-
tural insights into the tRNA recognition mechanism
for efficient modification.
INTRODUCTION
Posttranscriptional modifications at the first (wobble) position of
the tRNA anticodon are essential for precise decoding of the
genetic code (Bjo¨rk, 1995; Urbonavicius et al., 2001; Yokoyama
and Nishimura, 1995). In eubacteria, the 5-carboxymethylamino-
methyl (cmnm5) or 5-methylaminomethyl (mnm5) modification is
commonly found at the wobble uridine (U34) of tRNAGluUUC,
tRNALysUUU, tRNA
Gln
UUG, tRNA
Leu
UAA, and tRNA
Arg
UCU, where
a methylene carbon is directly bonded to the C5 atom of U34
(Figure 1) (Bjo¨rk, 1995; Yokoyama and Nishimura, 1995). For
translational fidelity, these tRNAs need to read two degenerate
codons ending with purine (NNR), which belong to the mixed
codon family boxes that assign two amino acids, according toStructure 17the difference in the third base of the codons. Biochemical and
structural studies have revealed the importance of these C5
substituents of U34 for stabilizing the correct codon-anticodon
pairing on the ribosome (Kurata et al., 2008; Murphy et al.,
2004; Urbonavicius et al., 2001; Yarian et al., 2000), which guar-
antees the incorporation of correct amino acids into proteins. In
addition to the modification at the 5-position, the tRNAs for Glu,
Lys, and Gln contain a 2-thio modification of U34, which is also
responsible for discriminating cognate from noncognate codons
during mRNA decoding (Ashraf et al., 1999; Urbonavicius et al.,
2001). These modifications at the 5- and 2-positions of U34 also
serve as determinants for tRNA recognition by the cognate ami-
noacyl-tRNA synthetases (Sylvers et al., 1993).
In eubacteria, two conserved proteins, GidA (glucose inhibited
division protein A) and MnmE (5-methylaminomethyluridine
forming enzyme E), are responsible for adding the cmnm5 group
to the 5-position of U34 (Figure 1) (Bre´geon et al., 2001; Elseviers
et al., 1984). In some eubacteria, such as Escherichia coli, the
cmnm5 group of U34 is then converted into the final mnm5 group
by MnmC (Figure 1) (Bujnicki et al., 2004). GidA and MnmE are
also conserved in Eukarya, where MSS1 and MTO1 have been
identified as their respective homologs in both human and yeast
(Colby et al., 1998; Decoster et al., 1993; Li and Guan, 2002; Li
et al., 2002). These proteins are localized in mitochondria and
are responsible for synthesizing the C5 substituent of U34 in
mitochondrial tRNAs (mt tRNAs) (Umeda et al., 2005). In contrast
to the cmnm5U modification observed in bacteria and yeast, the
humanmt tRNAs for Leu and Lys contain a 5-taurinomethyl (tm5)
group at the 5-position of U34 (Suzuki et al., 2002). Intriguingly,
the tm5U modification does not occur in the mt tRNAs isolated
from pathogenic cells of two human mitochondrial encephalo-
myopathies, MERRF (myoclonus epilepsy associated with
ragged-red fibers) (Yasukawa et al., 2000a) and MELAS (mito-
chondrial myopathy, encephalopathy, lactic acidosis, and
stroke-like episodes) (Yasukawa et al., 2000b), where a decoding
disorder arising from themodification defect is themain cause of
the mitochondrial dysfunction (Kirino et al., 2004; Yasukawa
et al., 2001). Disease-related point mutations in mt tRNA genes
are known to be responsible for the modification defect (Yasu-
kawa et al., 2000a, 2000b), suggesting that human MSS1 and, 713–724, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 713
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Crystal Structure of Aquifex aeolicus GidAFigure 1. Biosynthetic Pathway for the C5
Substituent at the Wobble Uridine in Bacte-
rial tRNAs Responsible for Purine-Ending
Split Codon Boxes
The chemical structures of uridine, cmnm5U, and
mnm5U are shown. The wobble uridine is first
modified to cmnm5Uby the collaborating activities
of both GidA and MnmE, and then cmnm5U is
further modified to mnm5U by MnmC.MTO1 cannot modify mt tRNAs with these pathogenic point
mutations.
GidA contains a consensus dinucleotide binding motif,
GXGXXG, a portion of the Rossman-fold domain, which is found
in a large number of flavin adenine dinucleotide (FAD) binding
proteins (Dym and Eisenberg, 2001). In fact, GidA binds FAD,
which has been proposed to be involved in the cmnm5U modifi-
cation process (Yim et al., 2006). However, the precise function
of GidA during the modification process remains elusive.
Biochemical studies have shown that GidA interacts with
MnmE to form a functional complex, suggesting that these two
proteins collaborate to modify the C5 atom of U34 in an interde-
pendent manner (Yim et al., 2006). The structural analysis of
MnmE revealed that it contains a tetrahydrofolate (THF) binding
domain and indeed interacts with 5-formyl-THF, which is
proposed to serve as a one-carbon donor for the cmnm5Umodi-
fication (Scrima et al., 2005). MnmE also contains a G-domain,
which is responsible for GTP binding and hydrolysis (Cabedo
et al., 1999; Scrima et al., 2005). Mutational analyses revealed
that effective GTP hydrolysis is crucial for the tRNA modifying
function, indicating that a structural rearrangement triggered
by GTP hydrolysis controls the cmnm5U modification process
(Yim et al., 2003). Taken together, GidA andMnmEmight employ
sophisticated mechanisms for controlling their activities to
perform the specific modification of U34. Although a few
possible reaction schemes were proposed for cmnm5U
synthesis (Scrima et al., 2005; Umeda et al., 2005; Yim et al.,
2006), the precise reaction mechanism catalyzed by both GidA
and MnmE remains to be elucidated.
It is of interest to note that GidA shares amino acid sequence
similarity with the FAD-dependent tRNA methyltransferase
TrmFO, which synthesizes 5-methyluridine (m5U) in position 54
of tRNA, using N5,N10-methylene-THF as the source of the
one-carbon unit (Urbonavicius et al., 2005). The sequence simi-
larity of these two proteins indicates that GidA and TrmFO have
evolved from a common ancestor, but acquired different cellular
functions. Although TrmFO alone is able to synthesize m5U, both
GidA andMnmE are indispensable for the cmnm5Umodification.
These findings suggest that, although the modification process
for synthesizing cmnm5U is rather complicated, the fundamental
reaction schemes for the m5U and cmnm5U modifications might
be similar.
Recently, the crystal structures of the GidAs from E. coli and
Chlorobium tepidum were determined at resolutions of about
3 A˚ (Meyer et al., 2008). These structures, together with a muta-
tional analysis, suggested the involvement of the C-terminal
region of GidA in the interaction withMnmE. However, themech-
anism of action of GidA in the cmnm5U modification process
remains elusive because of the lack of structural information714 Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All righabout the catalytic site in GidA. Here we report the crystal struc-
tures of Aquifex aeolicus GidA in two different crystal forms, at
resolutions of 2.3 A˚ and 3.2 A˚. The present structures indicate
that A. aeolicus GidA tightly interacts with FAD, and thus reveal
the precise location of the active site in GidA. We identified two
catalytic Cys residues crucial for the modification process, and
propose a novel reaction mechanism for cmnm5U synthesis. A
mutational analysis also suggested the tRNA binding surface of
GidA, and enabled us to construct a tRNA docking model. This
model could provide a structural explanation for the tm5Umodi-
fication defect in mt tRNAs with pathogenic point mutations.
RESULTS AND DISCUSSION
Overall Structure
Aquifex aeolicus GidA (AaGidA) was crystallized in two different
forms, I and II (Osawa et al., 2009). We first solved the form I
structure by the single anomalous dispersion method, using se-
lenomethionine (SeMet)-labeled crystals. The form I structure
was refined to an Rfree of 27.1% at 3.2 A˚ resolution. The current
model of the form I structure contains two molecules in the
asymmetric unit (molecules A and B) and includes residues
6–492 and 501–616 in molecule A and residues 6–492 and
501–614 in molecule B. Subsequently, the form II structure
was determined by the molecular replacement method, using
the form I structure as a searchmodel, andwas refined to anRfree
of 24.8% at 2.3 A˚ resolution. The current model of the form II
structure contains four molecules in the asymmetric unit (mole-
cules A, B, C, and D) and includes residues 1–266 and 282–
615 in molecule A, residues 1–270 and 282–615 in molecule B,
residues 1–270, 282–497, and 500–615 in molecule C, and resi-
dues 1–267 and 282–615 in molecule D. A clear electron density
corresponding to a portion of the His-tag sequence fused to the
N-terminus of AaGidA was also observed for all asymmetric
proteins in the form II crystal.
The overall structures of AaGidA in both crystal forms adopt
a very similar conformation, with an root-mean-square deviation
(rmsd) of 0.833 A˚ in the superimposition of the corresponding
587 Ca-atoms (data not shown). Meanwhile, the comparison of
these AaGidA structures revealed a difference in a loop region
(residues 266–286) connecting helices a7 and a8; that is,
although this region is partially disordered in the form II structure,
the form I is continuous, thereby indicating the structural
flexibility of this region (see below). The AaGidA protein is folded
into four structural domains, comprising the FAD-binding
domain (residues 1–43, 102–193, and 355–407), the insertion
domain 1 (Ins-1; residues 44–101), the insertion domain 2
(Ins-2; residues 194–354), and the helical domain (residues
408–617) (Figures 2 and 3A). The overall structure of AaGidAts reserved
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structural domains (Figure 3A). The AaGidA structure is similar
to the recently reported structures of the homologous proteins
from E. coli (EcGidA) and C. tepidum (CtGidA), determined at
2.9 A˚ and 3.2 A˚ resolutions, respectively (Meyer et al., 2008).
As shown in Figure 3B, AaGidA can be superimposed with
rmsd values of 1.599 A˚ and 2.349 A˚ over the corresponding
418 and 531 Ca atoms of EcGidA and CtGidA, respectively. It
should be noted that one-fourth of the total residues were not
included in the model of the EcGidA structure because of the
lack of electron density. The present AaGidA form II structure
has a remarkably small average thermal factor (29.5 A˚2), as
compared with those of the EcGidA and CtGidA structures
(88.5 A˚2 and 126.6 A˚2, respectively). As discussed in more detail
below, unlike the EcGidA and CtGidA structures, the AaGidA
structures revealed the tight interaction of GidA with FAD. There-
fore, the present higher-resolution structure analysis of the
AaGidA form II crystal allows us to discuss the structure-function
relationship in more detail and to identify the important residues
for the cmnm5U modification process (see below).
Gel filtration analysis revealed that GidA exists as a dimer in
solution (Yim et al., 2006). The asymmetric unit of the AaGidA
form II crystal contains four monomers, and these molecules
are related by noncrystallographic symmetry to form two inde-
pendent homodimers (Figure 3C). The overall architecture of
the homodimer is M-shaped (Figure 3C). The oligomerization
state of the AaGidA form I structure can also be arranged in
the samemanner as that of the form II crystal, and thisM-shaped
Figure 2. Amino Acid Sequence Alignment
of the GidA Proteins from Various Organ-
isms
The amino acid residue numbering of the A. aeoli-
cus GidA is indicated above the alignment,
whereas that of the E. coli GidA is shown below
the alignment. The secondary structure elements
of the A. aeolicus GidA are presented above the
alignment, with the following coloring scheme:
the FAD-binding domain is shown in cyan, the
insertion domain 1 (Ins-1) is green, the insertion
domain 2 (Ins-2) is magenta, and the helical
domain is yellow. Conserved residues and conser-
vative replacements are colored red and light blue,
respectively. Abbreviations are as follows: Aae,
Aquifex aeolicus; Tma, Thermotoga maritima;
Bsu, Bacillus subtilis; Hsa, Homo sapiens; Sce,
Saccharomyces cerevisiae; Eco, Escherichia coli.
dimer arrangement was also reported for
both the CtGidA and EcGidA structures
(Meyer et al., 2008). The molecular inter-
face is stabilized mainly by the well-
conserved interactions between the resi-
dues from the FAD-binding domain of one
monomer and the residues from Isn-2 of
the other (Figure 3C).
FAD Binding Site
The FAD-binding domain shares struc-
tural similarity with the glutathione reduc-
tase class of flavoproteins and contains a highly conserved
dinucleotide binding motif, which is known to interact with the
pyrophosphate moiety of FAD (Dym and Eisenberg, 2001; Ross-
mann et al., 1974). In both AaGidA structures, a clear electron
density corresponding to FAD was observed in a deep pocket
in all asymmetric proteins (Figure 3D). In contrast, in the crystal
structure of CtGidA, the FAD molecule was loosely bound at its
FAD binding site, with poor electron density for the isoalloxazine
moiety (Meyer et al., 2008). Moreover, no electron density for
FAD was observed in the EcGidA crystal, due to its dissociation
from the protein during the purification process (Meyer et al.,
2008). Therefore, the present AaGidA structures enable us for
the first time to accurately describe the intermolecular interac-
tions with FAD, and to perform a structure-based mutational
analysis. In the AaGidA structures, one FAD molecule is bound
noncovalently to each monomer in an extended conformation
(Figure 3D; see Figure S1 available online). The consensus dinu-
cleotide binding motif, GXGXXG (Gly14, Gly16, and Gly19 in
AaGidA) (Figure 2), interacts with the FAD pyrophosphate moiety
(Figure 3D; Supplemental Data). The importance of this motif for
the FAD binding has been suggested (Yim et al., 2006). The
details of the extensive interactions between AaGidA and FAD
are described in the Supplemental Discussion (see also
Figure S1).
Catalytic Site
It has been proposed that FAD-binding to GidA is required for
synthesizing cmnm5U (Yim et al., 2006). Therefore, the presentStructure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 715
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Crystal Structure of Aquifex aeolicus GidAFigure 3. Structure of Aquifex aeolicus GidA in the Form II Crystal
(A) Stereo view of the monomer structure of AaGidA. The FAD-binding domain (residues 1–43, 102–193, and 355–407), the insertion domain 1 (Ins-1; residues
44–101), the insertion domain 2 (Ins-2; residues 194–354), and the helical domain (residues 408–617) are colored cyan, green, magenta, and yellow, respectively.
The FAD molecule bound to the catalytic pocket is shown as a white stick model.
(B) Stereo view of the superimposition of AaGidA (cyan) on the EcGidA (green) andCtGidA (magenta) structures. The FADmolecules bound to AaGidA andCtGidA
are colored blue and red, respectively. The structure of AaGidA is in approximately the same orientation as in (A).
(C) Two views of the dimer structure of AaGidA. The protein molecule A and the two FAD molecules are colored as in (A), and the protein molecule B is shown in
white. Left: Front view of the dimer. Right: Top view of the dimer, which is rotated by 90 from the left panel.
(D) Stereo view of the FAD binding site of AaGidA. The FAD molecule is shown in yellow. The dinucleotide binding motif (residues 14–19) is red, and the residual
region of AaGidA is colored white. The simulated annealing omit map for the FAD molecule is contoured at 3.0 s and is colored blue.clear electron density, corresponding to the isoalloxazine moiety
of FAD, has unambiguously defined the catalytic pocket (active
site) of AaGidA (Figures 3A and 3D). In the AaGidA structure,
the isoalloxazine moiety is located at the interdomain cleft
between all four structural domains, with its pyrimidine ring
exposed to the solvent (Figures 3A and 4A,; Figure S1). The flavin
N3 and O4 atoms hydrogen bond with the Nh1 atom of Arg434
(3.35 A˚ and 3.27 A˚, respectively), and the flavin O2 atom
hydrogen bonds with the Nz atom of Lys57 (3.34 A˚) (Figures 4A;
Figure S1). These basic residues are strictly conserved among
the GidAs (Figure 2). The EcGidA mutants K56A and R427A
(Lys57 and Arg434 in AaGidA) exhibited a significant reduction
of the mnm5 incorporating activity, as judged by the nucleoside
analysis of tRNAs prepared from a log phase culture (Table 1). It
should be noted that, because of the catalytic activity of MnmC,
the cmnm5 group incorporated by the collaborating activities of
both GidA and MnmE is further modified to the mnm5 group in
E. coli cells (Figure 1). The flavin O2 and O4 atoms also form
water-mediated hydrogen bonds with protein residues (Figures
4A; Figure S1).
In the AaGidA structure, the loop between b2 and b3 in Ins-1 is
perfectly stacked on the si-side of the isoalloxazine ring
(Figure 4A). This loop contains the strictly conserved Cys48
(Figure 2), which lies just above the middle ring of the isoalloxa-
zine moiety, with its side-chain Sg atom in close contact with the
flavin N5 atom (Figure 4A). It is interesting to note that the loca-
tion of Cys48 relative to FAD is analogous to that of the catalytic716 Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All righCys residues in glutathione reductase (Karplus and Schulz,
1989). Glutathione reductase contains two conserved Cys resi-
dues (a redox active disulfide) near the isoalloxazine moiety of
FAD, to catalyze sequential thiol-disulfide interchange reactions,
in which FAD is involved in the reduction of a redox active disul-
fide for catalysis. Mutations of the corresponding residue in
EcGidA (C47A and C47S) did not complement the mnm5 incor-
porating activity in a log phase culture (Table 1). A nucleoside
analysis of the tRNAs from a full-grown culture should allow us
to detect the residual activity of the mutant proteins, which
cannot be detected by a nucleoside analysis of the tRNAs from
a log phase culture. To examine whether the mutation of
Cys47 in EcGidA causes the complete modification defect of the
tRNAs, we further analyzed the modification state of U34 of the
tRNAs from full-grown cultures. Bothmutations completely abol-
ished the mnm5 incorporating activity in the full-grown cultures
(Table 1; Figures 5C and 5D), revealing that Cys48 in AaGidA is
involved in the catalysis of the cmnm5U modifying reaction.
These results also suggest that the nucleobase of U34 should
be located near the isoalloxazine moiety during the modification
process. The side chains of the strictly conserved Thr202 and
Tyr315 hydrogen bond with the Sg atom of Cys48 (3.61 A˚ and
3.30 A˚, respectively) (Figure 4A). Mutations of the corresponding
residues in EcGidA impaired their activities in a log phase culture,
whereas these mutations seemed to show no effects in a full-
grown culture (Table 1). These results suggest that the side-
chain hydroxyl groups of these residues could be involved ints reserved
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modification reaction. In contrast, the two highly conserved
Thr200 and Thr382 residues are located at the re-side of the
isoalloxazine ring, with their side chains in close contact with
the flavin N5 and N1 atoms, respectively (Figure 4A). The corre-
sponding mutants in EcGidA did not complement the mnm5
incorporating activity in a log phase culture, whereas these
mutations had less of an effect in a full-grown culture (Table 1).
Thr200 and Thr382 might be indirectly involved in catalysis,
perhaps by stabilizing the isoalloxazine moiety during the modi-
fication reaction.
tRNA Binding Ability
The surface electrostatic potential revealed that the basic resi-
dues are clustered on one side of the GidA monomer, where
the active site cleft is located at the center of this region
(Figure 6A). This broad, positively charged region is composed
of well-conserved residues from Ins-1, Ins-2, and the helical
domain (Figure 6A). Furthermore, a large number of conserved
hydrophobic residues are dispersed in this region, and their
side chains face the solvent. These features of the GidA surface
strongly suggest that this region is a plausible candidate for the
tRNA binding site. Because a direct interaction between GidA
and tRNA has not been demonstrated, we investigated the
tRNA binding ability of GidA by a gel retardation analysis. As
shown in Figure 6B, AaGidA interacted with the in vitro tran-
scribed tRNALysUUU, with a Kd value in the nM order of magni-
tude, in agreement with the characteristic features of the GidA
surface. The difference in the two distinct shifted bands
(complexes I and II in Figure 6B) might represent the conforma-
tional diversity of the AaGidAdtRNA complex. In contrast, the gel
retardation analysis revealed that AaMnmE exhibited less affinity
toward tRNA, with a Kd value > 15 mM (Figure S2), in agreement
Figure 4. Catalytic Site
(A) Close-up stereo view of the active site in the
AaGidA form II structure. The ribbon representa-
tion of AaGidA is color coded as in Figure 3A.
FAD and the protein side-chains are colored
yellow and white, respectively. Water molecules
are shown as red spheres. Hydrogen bonds are
shown as dashed lines.
(B) Stereo view of the location of the second Cys
residue, Cys284, which is essential for the tRNA
modifying activity. Cys284 is situated on a flexible
loop between a7 and a8 (residues 266–286), which
is continuous and structured in the form I crystal
(pink), while a portion of this flexible loop is
partially disordered in the form II crystal (yellow).
Cys284 is located about 10-15 A˚ away from
Cys48.
with the absence of a significant, posi-
tively charged region on its molecular
surface that is suitable for the accommo-
dation of tRNA molecules (Scrima et al.,
2005). The band corresponding to the
AaGidAdtRNA complex was supershifted
in the presence of AaMnmE (data not
shown), suggesting the formation of the
ternary complex. This result is consistent with the interdepen-
dence between GidA and MnmE (Yim et al., 2006). Taken
together, these findings strongly suggest that GidA, but not
MnmE, is mainly responsible for the tRNA binding in the
GidAdMnmE complex during the modification process.
tRNA Docking Model
To study the precise tRNA recognition mechanism by GidA, we
explored the mutational effects of the conserved residues
around the catalytic pocket. In the AaGidA structures, the well-
conserved residues, Arg282, Lys290, and Lys293 in Ins-2, are
located on thewall of the catalytic pocket (Figure 6C). A gel retar-
dation analysis revealed that the mutant R282A/K290A/K293A
had significantly decreased tRNA binding ability (Figure 6D),
whereas the mutant R282A/K293A had slightly reduced tRNA
binding activity (Figure 6D), thus underscoring the importance of
Lys290 in tRNA binding. Consistent with this result, the EcGidA
mutant K283A (Lys290 in AaGidA) exhibited a drastic reduction
of themnm5 incorporating activity (Table 1). The EcGidAmutants
R275A and R286A (Arg282 and Lys293 in AaGidA) also had
decreased complementation activities (Table 1). Furthermore,
the strictly conserved Asn49 and Arg97 in Ins-1 are also located
around the catalytic pocket (Figure 6C). Mutations of the corre-
sponding residues in EcGidA (N48A and R96A) significantly
impaired the mnm5 incorporating activity (Table 1), suggesting
the involvement of these residues in the interaction with tRNA.
In the AaGidA structures, the loop between b4 and b5 in Ins-1,
together with the upper half region of the helical domain (resi-
dues 438–550 in AaGidA), protrudes from the catalytic pocket
to form a bulge structure (Figure 6A). In the AaGidA form I struc-
ture, a clear electron density, corresponding to a phosphate
ion, was observed in the bottom region of the bulge (Fig-
ure S3). This phosphate ion interacts with the side chains ofStructure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 717
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Crystal Structure of Aquifex aeolicus GidATable 1. In Vivo Complementation Analyses of the Wild-Type and Mutant EcGidA Proteins
EcGidA Mutant
Residue Number
in AaGidA Proposed Function
Complementation Activity
in Log-Phase Culture (%)
Complementation Activity
in Full-Grown Culture (%)
Wild-type — — 100 100
C47A Cys48 Catalysis 0 0
C47S Cys48 Catalysis 0 0
N48A Asn49 tRNA binding 29.1 —
K56A Lys57 FAD binding 15.1 93.1
R96A Arg97 tRNA binding 3.4 —
T199A Thr200 FAD stabilization 0 69.8
T201A Thr202 H-bond with Cys48 19.5 101.1
R275A Arg282 tRNA binding 56.1 —
C277S Cys284 Catalysis 0 0
K283A Lys290 tRNA binding 9.3 —
R286A Lys293 tRNA binding 59.4 —
Y308F Tyr315 H-bond with Cys48 11.9 92.9
T375A Thr382 FAD stabilization 0 91.1
R427A Arg434 FAD binding 36.2 91.8
R432A Arg439 tRNA binding 9.4 —
R436A Arg443 tRNA binding 0 —
R505A No counterpart tRNA binding 80.6 —
R514A No counterpart tRNA binding 82.1 —
R515A No counterpart tRNA binding 40.1 —
Y551A Tyr545 tRNA binding 25.7 —
R554A Arg548 tRNA binding 67.2 —the strictly conserved Arg439 and Arg443 (Figure S3). Because
these Arg residues are constituents of the basic patch on the
GidA surface (Figures 6A and 6C), this ion might mimic the phos-
phate moiety of the tRNA. The mutant R439A/R443A exhibited
markedly impaired tRNA binding activity (Figure 6D). In agree-
ment with this result, the EcGidA mutants R432A and R436A
(Arg439 and Arg443 in AaGidA) showed significantly impaired
mnm5 incorporating activity (Table 1). Therefore, these residues
are crucial for binding the tRNA to perform an efficient modifica-
tion reaction.
Based on these mutational experiments, we manually built
a docking model, using the AaGidA structure and E. coli tRNAGlu
with the flipped-out U34 (generated from Protein Data Bank
[PDB] ID 2DER) (Figure 7). In the model, the anticodon loop is
located in the catalytic pocket, such that the flipped-out U34 is
in close proximity to the isoalloxazine moiety of FAD, and the
anticodon stem is directed toward the bottom region of the bulge
(Figures 7A and 7B). Consequently, the tRNAD-stem is placed in
close contact with the distal end of the bulge (Figure 7A), where
the well-conserved Lys541, Tyr545, and Arg548 residues could
interact with the D-stem (Figure 7C). The mutant K541A/R548A
exhibited decreased tRNA binding ability (Figure 6D). In good
agreement with this, the EcGidA mutants Y551A and R554A
(Tyr545 and Arg548 in AaGidA) showed decreased mnm5 incor-
porating activity (Table 1). Our docking model also implies that
Arg491 and Arg501 are in close contact with the D-stem
(Figure 7C). The mutant R491A/R501A exhibited less affinity
toward tRNA (Figure 6D). Although there is no sequence conser-
vation in this region (residues 490–530 in AaGidA) (Figure 2),718 Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All righsome basic residues are located in similar positions, to form an
analogous electrostatic potential distribution among the GidAs.
Within this region in EcGidA, the mutation of Arg515, but not
the mutations of Arg505 and Arg514, considerably reduced the
mnm5 incorporating activity (Table 1), supporting the involve-
ment of this region in tRNA binding.
According to themodel, GidAmight recognize the bottom-half
region of the tRNA (Figure 7A) and might measure the distance
between the tRNA core and the anticodon loop in the L-shaped
tRNA, to ensure specific binding to intact tRNAs. The pathogenic
point mutations identified in the mt tRNAs in patients with
MERRF (Shoffner et al., 1990) or MELAS (Goto et al., 1990,
1991) occur in the D-arm, TJC-arm, and anticodon stem of
the tRNA. These disease-related mutations in mt tRNA genes
have been shown to affect the global tRNA structure by disrupt-
ing the secondary structure of the tRNA (Wittenhagen and Kelley,
2003), which is the main cause of the tm5U modification defect.
Considering the mechanistic similarities between the cmnm5U
and tm5U modifications (Suzuki et al., 2002; Umeda et al.,
2005), these findings might support the present tRNA docking
model, where GidA monitors the structural integrity of the tRNA.
Sequence comparisons of the tRNAs revealed that there are
no conserved nucleotide residues that are only found in the
tRNA substrates of GidA (data not shown). It is thus likely that
GidA predominantly interacts with the phosphate backbone of
the tRNA. It should be noted that U34 is also found in the tRNAs
that read four-fold degenerate codons, in which U34 is modified
to 5-hydroxyuridine derivatives to expand the degeneracy of
the genetic code. Therefore, GidA should have a strategy forts reserved
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bearing U34, to ensure the specific modification.
Identification of the Second Cys Residue Essential for
the Modification Process
Glutathione reductasecontains twoconservedCys residuesat its
active site to catalyze sequential thiol-disulfide interchange reac-
tions (Karplus and Schulz, 1989). In contrast, in the AaGidA struc-
ture, there is no other Cys residue within van der Waals contact
distance from Cys48 that is indispensable for the modification
reaction (Figure 4A). Intriguingly, the loop between a7 and a8,
which is located in the vicinity of the anticodon loop in the present
tRNA docking model, contains another Cys residue conserved
among the GidAs (Cys284 in AaGidA) (Figures 2 and 4B). This
cysteine resides about 10–15 A˚ away from the side chain of
Cys48 (Figure 4B). To explore the effect of Cys284 on the modi-
fying reaction, the corresponding residue in EcGidAwasmutated
to Ser. The resulting mutant (C277S) completely lacked mnm5
incorporating activity (Table 1; Figures 5C and 5E), suggesting
that Cys284 and Cys48 participate in catalysis, and that these
Figure 5. HPLC Chromatograms of tRNA
Hydrolysates
The nucleoside analyses of tRNA hydrolysates
prepared from full-grown cultures of (A)
W3110(DE3) (wild-type strain), (B) gidA-deficient
E. coli mutant strain, (C) gidA-deficient E. coli
mutant strain harboring the wild-type EcgidA
expression plasmid, (D) gidA-deficient E. coli
mutant strain harboring the EcgidA-C47S expres-
sion plasmid, (E) gidA-deficient E. coli mutant
strain harboring the EcgidA-C277S expression
plasmid, (F) mnmE-deficient E. coli mutant strain,
(G)mnmE-deficient E. colimutant strain harboring
the wild-type EcmnmE expression plasmid, and
(H)mnmE-deficient E. colimutant strain harboring
the EcmnmE-C451S expression plasmid. The
peaks corresponding to mnm5s2U and s2U are
marked by arrows.
Cys residues might function as a cysteine
pair during the modification process.
Although the loop between a7 and a8 in
the AaGidA form I crystal is continuous
and structured, that in the form II structure
is partially disordered in all asymmetric
proteins (Figure 4B). Therefore, this loop
isprobablyflexible. This region is alsoflex-
ible in the EcGidA and CtGidA structures
(Meyer et al., 2008). It is possible that the
side chain of Cys284 might be shifted
toward the catalytic site by the structural
rearrangement of this flexible loop upon
thebindingofGidA to tRNAand/orMnmE.
Novel Catalytic Mechanism
for cmnm5U Modification
The tm5U in mt tRNAs is synthesized by
the direct incorporation of taurine into
U34 (Suzuki et al., 2002). By analogy to
this mechanism, glycine is proposed to be incorporated into
U34, to form cmnm5U (Umeda et al., 2005). Previous studies re-
vealed that the gene products of both gidA andmnmE are indis-
pensable for adding the cmnm5 group to U34 (Bre´geon et al.,
2001; Elseviers et al., 1984). Based on these findings, two
possible models for the cmnm5U synthesis by GidA and MnmE
have been proposed (Figure S4). The first model involves GidA
and MnmE in a functional complex, which first synthesizes an
unknown nucleoside intermediate. Subsequently, an unidenti-
fied glycine transferase is proposed to catalyze glycine incorpo-
ration into the nucleoside intermediate, to accomplish the
cmnm5U modification (Umeda et al., 2005; Yim et al., 2006)
(Figure S4A). The second model involves GidA and MnmE inde-
pendently catalyzing sequential steps in the modifying reaction
(Bre´geon et al., 2001): based on the structural analysis of
MnmE complexed with 5-formyl-THF (Scrima et al., 2005),
MnmE is proposed to first catalyze the formyl transfer to produce
formylated U34 at the 5-position, and then a glycine molecule is
added to form a Schiff base, which in turn is reduced by GidA to
generate cmnm5U (Figure S4B).Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 719
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(A) Left: The surface electrostatic potential map of the AaGidA monomer in the form II crystal. Positively and negatively charged regions are colored blue and
red, respectively. The catalytic pocket and the bulge structure that protrudes from the active site cleft are marked. Right: Ribbon representation of the AaGidA
monomer in the same orientation as in the left panel, shown with the same coloring scheme as in Figure 3A. FAD is shown as a white stick model.
(B) Gel retardation analysis with increasing amounts of AaGidA (0-10 pmol). Two complexes, denoted as complexes I and II, were detected.
(C) Close-up stereo view around the catalytic pocket of the AaGidA form II structure. FAD and the protein side chains are colored yellow and white, respectively.
(D) The tRNA gel retardation analyses of the wild-type and mutant AaGidAs, with a 500 nM protein concentration.In the latter case, based on amutational study (Yim et al., 2003)
as well as by mechanistic analogy with thymidylate synthase
(Stroud and Finer-Moore, 2003) and the S-adenosylmethionine-
dependent m5Umethyl transferases (Lee et al., 2005), the strictly
conservedCys (Cys451 in EcMnmE) is proposed to attack theC6
atom of U34 as a catalytic residue, forming a covalent interme-
diate that increases the nucleophilicity at the 5-position of U34
(Scrima et al., 2005; Yim et al., 2003). To confirm the indispens-
ability of Cys451 of EcMnmE in the cmnm5U modification
process, we reinvestigated the role of this residue by an in vivo
mutational analysis. Unexpectedly, contrary to the previous
observation, our in vivo analysis revealed that the EcMnmE
mutant C451S retained some mnm5 incorporating activity
(24.0%) (Figures 5G and 5H), suggesting that Cys451 does not
act as acatalytic residue to attack theC6atomofU34. Asdemon-
strated by the two distinctly sensitive sets of in vivo analyses in
this study, i.e., the nucleoside analyses of tRNA prepared from
a log phase culture and a full-grown culture, the discrepancy720 Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All righbetween the previous and current reports could result from the
different growth conditions for the sample preparation and/or
the insufficient sensitivity of the nucleoside analyses. On the
other hand, comparable amounts of the undermodified form of
U34, s2U, accumulated in both the gidA- and mnmE-knockout
strains (Figures 5B and 5F; Yim et al., 2006), indicating that a hy-
pomodified nucleoside intermediate, such as a formylated
uridine, is not produced in either strain. Therefore, these results
do not support the proposal that GidA and MnmE independently
catalyze sequential steps in the modification process.
In the present study, we have demonstrated the critical impor-
tance of the two strictly conserved Cys residues, Cys48 and
Cys284, in and around the active site of GidA, for the cmnm5U
modification process (Table 1; Figures 5D and 5E). Moreover,
gel retardation analyses indicated that GidA, but not MnmE, is
predominantly responsible for the interaction with tRNA in the
GidAdMnmE complex (Figures 6B and S2). Therefore, it is most
likely that GidA, rather than MnmE, activates the 5-position ofts reserved
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could be supported by the observation that only s2U accumu-
lated in gidA deletion strains expressing either the C47S or
C277S EcGidA mutant protein (Figures 5D and 5E). By analogy
with the catalytic mechanism of thymidylate synthase (Stroud
and Finer-Moore, 2003), we propose here that one of the Cys
residues in GidA probably attacks the C6 atom of U34, which
in turn activates the C5 atom for a subsequent nucleophilic
attack on the incoming substituent (Figure 8). During catalysis,
the redox function of FAD might regulate the nucleophilicity of
the catalytic Cys residues for the modification reaction.
Aphylogenetic analysis revealed thatGidAandTrmFOevolved
froma commonancestor (Urbonavicius et al., 2005). The fact that
TrmFO alone catalyzes the formation of m5U at position 54 in
tRNA (Urbonavicius et al., 2005) might support our proposal
that GidA directly catalyzes the modification reaction at the
5-position of U34. Intriguingly, there are three strictly conserved
Cys residues among the TrmFO family proteins. Although the
reaction mechanism for synthesizing m5U by TrmFO remains
unclear, twoof the threeCys residues in TrmFOmight be involved
in the modification reaction, as in the case of GidA.
We cannot rule out the possibility that cmnm5U is synthesized
via an unidentified nucleoside intermediate (Figure S4A).
However, such a nucleoside intermediate has not been reported.
This could suggest that the cmnm5 substituent is directly incor-
porated into U34, where an intermediate precursor of the cmnm5
Figure 7. tRNA Docking Model
(A) Ribbon representation of the docking model of
the AaGidA monomer and E. coli tRNAGlu (PDB ID:
2DER). AaGidA is shown with the same coloring
scheme as in Figure 3A. tRNAGlu is colored
orange, and the flipped out U34 is marked. FAD
is shown as a white stick model.
(B and C) Close-up views of the interface between
AaGidA and the modeled tRNA, showing the inter-
actions between the anticodon stem loop and the
catalytic pocket of AaGidA (B) and the distal end of
the bulge and the D-stem of the tRNA (C). The
conserved residues found at the distal end of the
bulge are shown as white stick models.
group might be synthesized by the
collaborating activity of the GidAdMnmE
complex. At present, we have not been
able to reconstitute the in vitro modifica-
tion reaction of tRNA using purified
components. Therefore, the establish-
ment of an in vitro reconstitution system
for synthesizing cmnm5U and the deter-
mination of the complex structures, including GidA, MnmE,
and tRNA, are prerequisites for shedding light on the precise
mechanisms for the formation of this hypermodified nucleoside
at the wobble position of the tRNA.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The gene encoding GidA from A. aeolicus was amplified by polymerase chain
reaction (PCR) from genomic DNA and cloned into the pET28b expression
vector. The recombinant protein, referred to as AaGidA (molecular mass of
69.6 kDa), was produced in E. coli strain BL21-CodonPlus (DE3)-RIL. The har-
vested E. coli cells were lysed by sonication in lysis buffer containing 20 mM
Tris-HCl (pH 8.0), 300 mM NaCl, 10 mM imidazole, 7 mM b-mercaptoethanol,
1 mM phenylmethylsulphonyl fluoride, and 1 mM benzamidine. After the cell
debris was removed by centrifugation at 8000 rpm for 30 min, the supernatant
was subjected to heat treatment at 65C for 20 min. The heat-denatured
proteins were removed by centrifugation at 8000 rpm for 30 min, and then
the recombinant AaGidA was purified by chromatography on Ni-NTA agarose,
Resource S, and HiTrap Heparin columns. The purified AaGidA was dialyzed
against 20mMTris-HCl (pH 8.0), 100mMNaCl, and 7mM b-mercaptoethanol,
and was concentrated to 5–10 mg/ml. The protein concentration of AaGidA
was determined using the molar extinction coefficient of 79,440 M1 cm1
at 280 nm. The SeMet-labeled AaGidA was produced in the methionine auxo-
troph E. coli strain B834-CodonPlus (DE3)-RIL, and was purified using the
same procedure as that for the native protein.
The gene encoding A. aeolicus MnmE, referred to as AaMnmE (molecular
mass of 50.3 kDa), was PCR-amplified from genomic DNA and then cloned
into the plasmid pET28b. The recombinant AaMnmE was produced in E. coliFigure 8. Novel Mechanism for the GidA-
Catalyzed Reaction
The catalytic Cys residue of GidA attacks the C6
atom of U34, which in turn increases the nucleo-
philicity of the C5 atom. The C5 atom then
performs a nucleophilic attack on the incoming
substituent, producing a covalent adduct of the
cmnm group or an unidentified substituent at the
5-position of U34.Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All rights reserved 721
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Crystal Structure of Aquifex aeolicus GidAstrain BL21-CodonPlus (DE3)-RIL, and was purified by a series of chromatog-
raphy steps onNi-NTA agarose, ResourceQ, HiTrapHeparin, andHiTrap Butyl
columns. The purified AaMnmE was dialyzed against 10 mM Tris-HCl buffer
(pH 8.0) containing 50 mM NaCl, 5 mM MgCl2, and 1 mM dithiothreitol, and
was then concentrated. The protein concentration of AaMnmE was deter-
mined using the Bradford method, with bovine serum albumin as the standard
protein. The analytical gel filtration experiment suggested that AaMnmE exists
as a dimer in solution.
Crystallization and Data Collection
The AaGidA protein was crystallized in two different forms, I and II, using the
vapor diffusionmethod, bymixing 1 ml protein solution (5mg/ml) and 1 ml home-
Table 2. Summary of Data Collection, Phasing, and Refinement
Statistics
SeMet (Form I Crystal)
Native
(Form II Crystal)
Data collection
Wavelength (A˚) 0.97928 1.0
Resolution (A˚) 50-3.20 (3.26-3.20) 50-2.30 (2.33-2.30)
Unique reflections 41,584 123,831
Redundancy 8.0 (5.1) 3.7 (2.5)
Completeness (%) 99.5 (99.3) 92.2 (78.5)
I/s(I) 11.5 (2.2) 12.2 (2.0)
Rsym
a 0.126 (0.398) 0.083 (0.248)
Phasing statistics
No. of sites 22
Phasing power 1.09
Rcullis
b 0.820
Figure of Merit 0.288
Refinement statistics
Resolution (A˚) 20-3.2 20-2.3
Rwork (%)
c / Rfree (%)
d 24.2 / 27.1 20.9 / 24.8
Number of atoms
Protein 9,595 19,272
Ion 15 0
Water 0 1,100
Average B-factor (A˚2) 71.1 29.5
Rmsd
Bond lengths (A˚) 0.009 0.006
Bond angles () 1.4 1.2
Dihedral angles () 22.9 23.0
Improper angles () 0.91 0.83
Ramachandran plot
Core region (%) 82.4 93.1
Additionally allowed
region (%)
17.6 6.9
Generously allowed
region (%)
0 0
Disallowed region (%) 0 0
The numbers in parentheses are for the last shell.
a Rsym = SjIavg – Iij/SIi.
b Rcullis = SjjFPH + FPj - FH(calc)j/ SjFPHj.
c Rwork = SjFo – Fcj/SFo for reflections of the working set.
d Rfree = SjFo – Fcj/SFo for reflections of the test set (5.0% of total reflec-
tions).722 Structure 17, 713–724, May 13, 2009 ª2009 Elsevier Ltd All righmade reservoir solution (Osawa et al., 2009). The AaGidA form I crystals were
obtained within 3 days, using a reservoir containing 1.0 M sodium/potassium
phosphate (pH 6.9). The AaGidA form II crystals grew within 2 weeks, using
a reservoir containing 200 mM ammonium chloride and 20% (w/v) PEG3350.
For data collection, the AaGidA form I and II crystals were cryoprotected in
their respective reservoir solutions containing 20% ethylene glycol and 20%
glycerol, respectively, and were then flash-cooled in a nitrogen stream at
100 K. The diffraction data were collected at the beamlines NW12A, BL-5A,
and BL-17A of KEK (Ibaraki, Japan), and were processed with the program
HKL2000 (Otwinowski and Minor, 1997). The SeMet-labeled AaGidA form I
crystals diffracted to 3.2 A˚ and belonged to the orthorhombic space group
I212121, with unit cell dimensions of a = 101.6 A˚, b = 213.3 A˚, and c = 231.7 A˚,
with two AaGidA molecules in the asymmetric unit. The AaGidA form II crystals
diffracted to 2.3 A˚ and belonged to the monoclinic space group P21, with unit
cell parameters of a = 119.4 A˚, b = 98.0 A˚, c = 129.6 A˚, and b = 90.0. There are
four AaGidA molecules in the asymmetric unit of the form II crystals. The pro-
cessing statistics are summarized in Table 2.
Structure Determination and Refinement
The structure of the AaGidA form I crystal was first determined by the single
anomalous dispersion (SAD) method, using SeMet-labeled AaGidA. Initial
selenium sites for SAD phasing were identified with the program SnB (Weeks
and Miller, 1999). The selenium parameters were refined and the phases were
calculated at 3.5 A˚ resolution, using the program SHARP (de La Fortelle and
Bricogne, 1997). The subsequent solvent flattening was performed with the
program RESOLVE (Terwilliger, 2000) or DM (CCP4, 1994). The initial model
was manually built, using the program Coot (Emsley and Cowtan, 2004). Iter-
ative cycles of refinement with CNS (Bru¨nger et al., 1998) and manual
rebuilding with Coot were performed at 3.2 A˚ resolution, until the Rfree factor
converged. The structure of the AaGidA form II crystal was solved at 2.3 A˚
resolution, by molecular replacement with the program PHASER (CCP4,
1994), using the refined AaGidA form I structure as a searchmodel. The stereo-
chemistry of the models was verified using PROCHECK (Laskowski et al.,
1993). The phasing and refinement statistics are summarized in Table 2.
Molecular graphics were illustrated with PyMol (http://www.pymol.org).
In Vivo Mutational Analysis and Gel Retardation Assay
The details of the construction of E. coli mutant strains, the in vivo mutational
analysis, and the gel retardation assay are described in the Supplemental Data.
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